Federal Data Hub › HRSA 340B · JSON
340B ID CAH231337-00
ParticipatingCritical Access Hospital
St Francis Hospital is a Critical Access Hospital enrolled in the federal 340B Drug Pricing Program in Escanaba, MI. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 19 contract-pharmacy arrangement(s) (6 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ACRO PHARMACEUTICAL SERVICES LLC | SHARON HILL, PA | 2017-01-01 | 2019-07-10 | 1139 |
| COMMCARE PHARMACY-FTL, LLC | PLANTATION, FL | 2017-01-01 | 2019-07-10 | 8333 |
| MEIJER DISTRIBUTION INC #90 | GRAND RAPIDS, MI | 2019-10-01 | — | 4387 |
| MEIJER PHARMACY #294 | ESCANABA, MI | 2019-10-01 | — | 110287 |
| MEIJER PHARMACY #464 | BELLEVILLE, MI | 2019-10-01 | — | 106590 |
| MEIJER STORES LIMITED PARTNERSHIP | FORT WAYNE, IN | 2019-10-01 | — | 10526 |
| ONCO360 | HOUSTON, TX | 2020-10-01 | 2021-01-07 | 120441 |
| ONCOMED PHARMACEUTICAL SERVICES OF MA, L | WALTHAM, MA | 2020-10-01 | 2021-01-07 | 93446 |
| ONCOMED THE ONCOLOGY PHARMACY OF BUFFALO | AMHERST, NY | 2020-10-01 | 2021-01-07 | 5970 |
| SHOPKO PHARMACY #2016 | ESCANABA, MI | 2014-01-01 | 2019-01-26 | 55168 |
| SINA DRUG LLC | WOODRIDGE, IL | 2020-10-01 | 2021-01-07 | 123044 |
| SINA DRUG LLC | LOUISVILLE, KY | 2020-10-01 | 2022-07-06 | 92134 |
| SINA DRUG LLC | NEW HYDE PARK, NY | 2020-10-01 | 2022-07-06 | 4147 |
| SORKIN'S RX LTD | NEW HYDE PARK, NY | 2020-10-01 | 2022-07-06 | 19662 |
| WAL-MART CENTRAL FILL 10-2670 | SPRING, TX | 2020-07-01 | 2023-09-29 | 70688 |
| WAL-MART PHARMACY 10-2522 | ESCANABA, MI | 2013-04-01 | 2023-09-29 | 11190 |
| WAL-MART PHARMACY 10-5997 | ORLANDO, FL | 2020-07-01 | 2023-09-29 | 39270 |
| WALGREEN CO. | ESCANABA, MI | 2014-01-01 | — | 10964 |
| Walgreens Central Fill #21426 | Brooklyn Park, MN | 2025-10-01 | — | 146339 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.